Division of Biochemistry, Central Drug Research Institute, Post Box No. 173, Chatter Manzil Palace, Lucknow 226001, India.
Exp Parasitol. 2011 Dec;129(4):368-74. doi: 10.1016/j.exppara.2011.08.021. Epub 2011 Sep 16.
Plasmodium lacks the de novo pathway for purine biosynthesis and relies exclusively on the salvage pathway. Adenosine deaminase (ADA), first enzyme of the pathway, was purified and characterized from Plasmodium yoelii, a rodent malarial species, using ion exchange and gel exclusion chromatography. The purified enzyme is a 41 kDa monomer. The enzyme showed K(m) values of 41 μM and 34 μM for adenosine and 2'-deoxyadenosine, respectively. Erythro-9-(2-hydroxy-3-nonyl) adenine competitively inhibited P. yoelii ADA with K(i) value of 0.5 μM. The enzyme was inhibited by DEPC and protein denaturing agents, urea and GdmCl. Purine analogues significantly inhibited ADA activity. Inhibition by p-chloromercuribenzoate (pCMB) and N-ethylmaleimide (NEM) indicated the presence of functional -SH groups. Tryptophan fluorescence maxima of ADA shifted from 339 nm to 357 nm in presence of GdmCl. Refolding studies showed that higher GdmCl concentration irreversibly denatured the purified ADA. Fluorescence quenchers (KI and acrylamide) quenched the ADA fluorescence intensity to the varied degree. The observed differences in kinetic properties of P. yoelii ADA as compared to the erythrocyte enzyme may facilitate in designing specific inhibitors against ADA.
疟原虫缺乏从头合成嘌呤的途径,完全依赖补救途径。腺苷脱氨酶(ADA)是该途径的第一个酶,从啮齿动物疟原虫 Plasmodium yoelii 中通过离子交换和凝胶排除色谱法进行了纯化和特性研究。纯化的酶是一个 41 kDa 的单体。该酶对腺苷和 2'-脱氧腺苷的 K(m)值分别为 41 μM 和 34 μM。Erythro-9-(2-hydroxy-3-nonyl) adenine 以 K(i)值为 0.5 μM 竞争性抑制 P. yoelii ADA。该酶被 DEPC 和蛋白变性剂、尿素和 GdmCl 抑制。嘌呤类似物显著抑制 ADA 活性。对 p-氯汞苯甲酸 (pCMB) 和 N-乙基马来酰亚胺 (NEM) 的抑制表明存在功能 -SH 基团。ADA 的色氨酸荧光最大值在 GdmCl 存在下从 339nm 转移到 357nm。复性研究表明,较高的 GdmCl 浓度会使纯化的 ADA 不可逆变性。荧光猝灭剂 (KI 和丙烯酰胺) 不同程度地猝灭 ADA 的荧光强度。与红细胞酶相比,P. yoelii ADA 的动力学特性的差异可能有助于设计针对 ADA 的特异性抑制剂。